In this section
Cardiovascular Disease Research
This study aims to better understand the causes of hypoxia during haemodialysis by investigating changes in pH, cardiac output, white blood cell count and oxygen status.
Recently, the SARS-CoV2 virus has spread rapidly across the globe and has claimed the lives of over 1.1 million people. The virus has led to a state of health emergency in many countries, as well as economic devastation. The scientific community has been working to determine how the virus infects host cells and to identify the contributing genetic factors.
Sodium Glucose Co-Transporter inhibitors have been shown to improve major cardiovascular outcome events including cardiovascular mortality.
It has been shown that heart disease is a condition associated with compounds produced by the gut bacteria, Klebsiella, the main one is a metabolite named trimethylamine, or TMA.
Early cardiac rehabilitation exercise training for patients after cardiac surgery: a randomised controlled trial
Coronary Artery Bypass Graft (CABG) and heart Valve Replacement (VR) operations are common treatments for heart disease and involve cutting through the central chest bone to expose the heart. Pain and loss of strength following this surgery can persist for up to 12 months leaving many patients unable to perform every day activities or return to work. Cardiac rehabilitation exercise (CR) improves recovery and reduces complication
The characterisation of vascular biomarkers and body composition before and after cardiac resynchronisation therapy in patients with chronic heart failure and their role in predicting response.
Heart failure is a common and disabling condition which has a higher death rate than most cancers. The problem continues to expand, despite really effective medical treatments. When patients develop heart failure their heart shape and function alters for the worse.